A detailed history of Pya Waltman Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pya Waltman Capital, LLC holds 10,620 shares of AMGN stock, worth $3.06 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
10,620
Previous 10,178 4.34%
Holding current value
$3.06 Million
Previous $3.18 Million 7.58%
% of portfolio
1.27%
Previous 1.31%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$309.38 - $337.38 $136,745 - $149,121
442 Added 4.34%
10,620 $3.42 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $167,371 - $203,400
637 Added 6.68%
10,178 $3.18 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $362,167 - $437,182
1,347 Added 16.44%
9,541 $2.71 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $137,822 - $155,479
539 Added 7.04%
8,194 $2.36 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $335,190 - $416,148
1,533 Added 25.04%
7,655 $2.06 Million
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $348,403 - $411,979
1,626 Added 36.17%
6,122 $1.36 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $348,845 - $425,184
1,545 Added 52.36%
4,496 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $122,531 - $155,690
535 Added 22.14%
2,951 $775,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $384,948 - $434,152
1,715 Added 244.65%
2,416 $545,000
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $127,121 - $141,463
551 Added 367.33%
701 $171,000
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $29,832 - $34,140
150 New
150 $34,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pya Waltman Capital, LLC Portfolio

Follow Pya Waltman Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pya Waltman Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pya Waltman Capital, LLC with notifications on news.